Abdou YG - Search Results

1

Germline Genetic Testing in Breast Cancer: Systemic Therapy Implications.

Bhardwaj PV, Abdou YG. Bhardwaj PV, et al. Among authors: abdou yg. Curr Oncol Rep. 2022 Dec;24(12):1791-1800. doi: 10.1007/s11912-022-01340-x. Epub 2022 Oct 18. Curr Oncol Rep. 2022. PMID: 36255604 Review.

2

Advances in the Management of Early-Stage Triple-Negative Breast Cancer.

Bhardwaj PV, Wang Y, Brunk E, Spanheimer PM, Abdou YG. Bhardwaj PV, et al. Among authors: abdou yg. Int J Mol Sci. 2023 Aug 5;24(15):12478. doi: 10.3390/ijms241512478. Int J Mol Sci. 2023. PMID: 37569851 Free PMC article. Review.

3

The Evolving Landscape of Immune Checkpoint Inhibitors and Antibody Drug Conjugates in the Treatment of Early-Stage Breast Cancer.

Bhardwaj PV, Abdou YG. Bhardwaj PV, et al. Among authors: abdou yg. Oncologist. 2023 Oct 3;28(10):832-844. doi: 10.1093/oncolo/oyad233. Oncologist. 2023. PMID: 37597245 Free PMC article. Review.

4

Navigating Treatment Pathways in Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: Optimizing Second-Line Endocrine and Targeted Therapies.

Bhardwaj PV, Abdou Y. Bhardwaj PV, et al. J Clin Oncol. 2024 Dec;42(34):4012-4017. doi: 10.1200/JCO-24-01295. Epub 2024 Sep 18. J Clin Oncol. 2024. PMID: 39292976 Review.

5

COVID-19 and Cancer: a Comprehensive Review.

Gosain R, Abdou Y, Singh A, Rana N, Puzanov I, Ernstoff MS. Gosain R, et al. Curr Oncol Rep. 2020 May 8;22(5):53. doi: 10.1007/s11912-020-00934-7. Curr Oncol Rep. 2020. PMID: 32385672 Free PMC article. Review.

6

Significance of the Genomic Landscape of a De Novo Endocrine-Resistant Metastatic Hormone Receptor-Positive Breast Cancer.

Sarma M, Abdou Y, Dhakal A, Gandhi S. Sarma M, et al. Breast Cancer (Auckl). 2020 Dec 16;14:1178223420976387. doi: 10.1177/1178223420976387. eCollection 2020. Breast Cancer (Auckl). 2020. PMID: 33402826 Free PMC article.

7

Left sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancer.

Abdou Y, Gupta M, Asaoka M, Attwood K, Mateusz O, Gandhi S, Takabe K. Abdou Y, et al. Sci Rep. 2022 Aug 4;12(1):13377. doi: 10.1038/s41598-022-16749-4. Sci Rep. 2022. PMID: 35927418 Free PMC article.

8

Immunotherapy in triple negative breast cancer: beyond checkpoint inhibitors.

Abdou Y, Goudarzi A, Yu JX, Upadhaya S, Vincent B, Carey LA. Abdou Y, et al. NPJ Breast Cancer. 2022 Nov 9;8(1):121. doi: 10.1038/s41523-022-00486-y. NPJ Breast Cancer. 2022. PMID: 36351947 Free PMC article. Review.

9

Intratumoral delivery of immunotherapy to treat breast cancer: current development in clinical and preclinical studies.

Mantooth SM, Abdou Y, Saez-Ibañez AR, Upadhaya S, Zaharoff DA. Mantooth SM, et al. Front Immunol. 2024 May 13;15:1385484. doi: 10.3389/fimmu.2024.1385484. eCollection 2024. Front Immunol. 2024. PMID: 38803496 Free PMC article. Review.

10

A Phase I Trial of Alpelisib Combined With Capecitabine in Patients With HER2-Negative Metastatic Breast Cancer.

File DM, Abdou Y, Force J, Moore DT, Anders CK, Reeder-Hayes K, Carey LA, Muss HB, Perou CM, Marcom PK, Dees EC. File DM, et al. Clin Breast Cancer. 2024 Dec;24(8):683-690. doi: 10.1016/j.clbc.2024.08.001. Epub 2024 Aug 8. Clin Breast Cancer. 2024. PMID: 39217059 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters